Navigation Links
For Juvenile Arthritis, Pill May Work as Well as Needle

THURSDAY, May 31 (HealthDay News) -- Taking the arthritis drug methotrexate in pill form was just as effective as receiving it by injection for the long-term treatment of children with juvenile rheumatoid arthritis, a new study has found.

Since both methods also have a similar incidence of side effects, researchers said the findings suggest that children may as well take the medication as a pill instead of having to put up with the discomfort of injections.

They noted, however, that their study looked back at registry information on kids with arthritis. More research -- including controlled clinical trials, the gold standard of research -- is needed before making a treatment recommendation.

The study, published May 30 in the journal Arthritis Care & Research, was funded by drug maker Wyeth BioPharma.

Methotrexate (brand name Rheumatrex) is one of the most common first-line disease-modifying antirheumatic drug treatments for arthritis.

In this study, German researchers compared more than 150 patients who received methotrexate injections and more than 250 patients who took the drug orally. The male and female patients, who had a median age of 10, all received comparable doses.

After six months of treatment, nearly three-quarters of patients -- including 73 percent receiving injections and 72 percent receiving the pill form -- showed a response to the drug. At least one negative side effect was reported in 27 percent of those receiving injections and 22 percent of those on the oral drug.

Eleven percent of patients receiving injections stopped treatment due to negative side effects, compared with 5 percent of those on oral therapy, the researchers noted.

Juvenile rheumatoid arthritis, also called juvenile idiopathic arthritis, affects between 10 and 100 per 100,000 children younger than 16. It is the most common chronic inflammatory disease in children and can lead to severe disability. About 294,000 U.S. children have the disease, according to the American College of Rheumatology.

One expert in the United States agreed that methotrexate seemed to work equally well regardless of how the children received it.

"Methotrexate is one of the disease-modifying agents used to treat arthritis -- it can be taken as a pill or as a subcutaneous [under the skin] injection and pediatric rheumatologists have felt that the parenteral route (injection) has been the most efficacious," said Dr. B. Anne Eberhard, a pediatric rheumatologist at Cohen Children's Medical Center in New Hyde Park, N.Y. However, she added, "this study from Germany suggests otherwise."

Still, while some children did experience "significant improvement in their arthritis" with methotrexate, most patients "did not achieve remission in their illness, which is the ultimate aim in treating children with juvenile idiopathic arthritis," Eberhard noted.

More information

The Nemours Foundation has more about juvenile rheumatoid arthritis.

-- Robert Preidt

SOURCES: B. Anne Eberhard, M.D., pediatric rheumatologist, Cohen Children's Medical Center, New Hyde Park, N.Y.; Arthritis Care & Research, news release, May 30, 2012

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Injection of methotrexate not superior to oral therapy in juvenile arthritis treatment
2. Children with juvenile arthritis have higher rates of bacterial infection
3. Social workers should reclaim role in juvenile corrections system, MU researcher says
4. Study identifies factors linked with better medication response for treatment of juvenile arthritis
5. Sonography complements physical exam in identifying juvenile inflammatory arthritis in children
6. Better HIV prevention interventions needed for juvenile offenders
7. New clinical practice guidelines developed for juvenile idiopathic arthritis
8. Doctor Shortage Adds to Pain of Juvenile Arthritis
9. Biologics-naive juvenile idiopathic arthritis patients have elevated risk of cancer
10. Montreal researchers shed light on common juvenile cancer
11. Most states offer HPV vaccinations to girls in juvenile justice system
Post Your Comments:
Related Image:
For Juvenile Arthritis, Pill May Work as Well as Needle
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... and clinical solutions for the care management and population health arenas, is pleased ... providing clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ ...
(Date:12/1/2015)... Atlanta, GA (PRWEB) , ... December 01, 2015 ... ... manufacturing, supports SACC-GA and SACC-USA through membership and leadership since 2008. ... and Chair for SACC-USA . Gary has spent a significant amount of ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. ... a Modern Man for 2015. , Angeleno Magazine is a division of ... Established in 1994, Modern Luxury includes more than 50 magazine titles across 15 ...
(Date:11/30/2015)... ... November 30, 2015 , ... Third Molar SEO ... it has officially launched a sleek, mobile-ready and user-centric redesigned website. , Vivek ... website clearly outlines the benefits that its SEO services provide to dentists and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... a leader in intelligent sensors and analytic software for sensor network-based systems, announced the OS-3008 ... of vital signs. Photo - ... ... ... This ...
(Date:12/1/2015)... Dec. 1, 2015  ImmunoCellular Therapeutics, Ltd. ... Andrew Gengos , President and Chief Executive ... December 3, 2015. Mr. Gengos plans to ... program in patients with newly diagnosed glioblastoma ... TIME:    12:15p.m. ET/9:15a.m. PT LINK: ...
(Date:12/1/2015)... December 1, 2015 ... addition of the  "2016 Shigella Testing ... Technologies, Competitive Strategies, Emerging Opportunities--US, Europe ...  report to their offering. --> ... addition of the  "2016 Shigella Testing ...
Breaking Medicine Technology: